Everolimus in combination with rituximab induces complete responses in heavily pretreated diffuse large B-cell lymphoma

Everolimus in combination with rituximab induces complete responses in heavily pretreated diffuse large B-cell lymphoma

Diffuse large B-cell lymphoma is an aggressive non-Hodgkin's lymphoma without a standard therapy for patients who relapse after or are not eligible for salvage autologous stem cell transplantation. In vitro analysis of lymphoma cell lines has shown that everolimus can inhibit cell cycle progres...

Full description

Bibliographic Details
Main Authors: Jeffrey A. Barnes, Eric Jacobsen, Yang Feng, Arnold Freedman, Ephraim P. Hochberg, Ann S. LaCasce, Philippe Armand, Robin Joyce, Aliyah R. Sohani, Scott J. Rodig, Donna Neuberg, David C. Fisher, Jeremy S. Abramson
Format: Article
Language:English
Published: Ferrata Storti Foundation 2013-04-01
Series:Haematologica
Online Access:https://haematologica.org/article/view/6632

Internet

https://haematologica.org/article/view/6632

Similar Items